Literature DB >> 9050867

Multiple promoter elements differentially regulate the expression of the mouse tenascin gene.

D W Copertino1, G M Edelman, F S Jones.   

Abstract

Tenascin (TN) is an extracellular matrix glycoprotein that is expressed in a characteristic spatiotemporal pattern during development and is up-regulated in the adult during tumorigenesis, wound healing, and nerve regeneration. In previous studies, we identified a promoter within the proximal 250 bp upstream of the mouse TN gene that contains several putative regulatory elements that are conserved among vertebrate TN genes. We have identified four different DNA elements within this promoter and show that they contribute in different ways to TN gene expression in NIH 3T3 fibroblasts, C6 glioma cells, and N2A neuroblastoma cells. These elements comprise a binding site for Krox proteins, one for nuclear factor 1, an octamer motif that binds POU-homeodomain proteins, and a novel TN control element. The nuclear factor 1 and TN control element had positive effects on TN promoter activity and formed similar DNA-protein complexes with nuclear extracts from all three cell lines. The Krox element had a negative effect on TN promoter activity in N2A cells, a positive effect in C6 cells, and no effect in NIH 3T3 cells. Two DNA binding complexes, one correlated with the negative and the other with the positive activities of the Krox element, were found to contain the protein Krox24. In cotransfection experiments, the octamer motif was required for induction of TN promoter activity by the POU-homeodomain protein Brn2 in N2A cells but was inactive in C6 cells. Consistent with these findings, N2A cells transfected with Brn2 formed octamer-binding complexes containing N-Oct3, the transcriptionally active form of Brn2, whereas complexes formed in C6 cells contained only N-Oct5A and N-Oct5B. Our results provide a striking example of the diversity of regulatory mechanisms that can be called forth by combining different promoter motifs with transcriptional activators or repressors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9050867      PMCID: PMC20005          DOI: 10.1073/pnas.94.5.1846

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  In situ detection of sequence-specific DNA binding activity specified by a recombinant bacteriophage.

Authors:  C R Vinson; K L LaMarco; P F Johnson; W H Landschulz; S L McKnight
Journal:  Genes Dev       Date:  1988-07       Impact factor: 11.361

2.  A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-beta.

Authors:  P Rossi; G Karsenty; A B Roberts; N S Roche; M B Sporn; B de Crombrugghe
Journal:  Cell       Date:  1988-02-12       Impact factor: 41.582

Review 3.  POU-domain proteins: structure and function of developmental regulators.

Authors:  M Wegner; D W Drolet; M G Rosenfeld
Journal:  Curr Opin Cell Biol       Date:  1993-06       Impact factor: 8.382

4.  Identification of BMP-4 as a signal mediating secondary induction between epithelial and mesenchymal tissues during early tooth development.

Authors:  S Vainio; I Karavanova; A Jowett; I Thesleff
Journal:  Cell       Date:  1993-10-08       Impact factor: 41.582

5.  Stimulation of human neuronectin secretion by brain-derived growth factors.

Authors:  W J Rettig; T J Triche; P Garin-Chesa
Journal:  Brain Res       Date:  1989-05-15       Impact factor: 3.252

6.  A family of human CCAAT-box-binding proteins active in transcription and DNA replication: cloning and expression of multiple cDNAs.

Authors:  C Santoro; N Mermod; P C Andrews; R Tjian
Journal:  Nature       Date:  1988-07-21       Impact factor: 49.962

7.  Contactpoint analysis of the HeLa nuclear factor I recognition site reveals symmetrical binding at one side of the DNA helix.

Authors:  E de Vries; W van Driel; S J van den Heuvel; P C van der Vliet
Journal:  EMBO J       Date:  1987-01       Impact factor: 11.598

8.  Tenascin: cDNA cloning and induction by TGF-beta.

Authors:  C A Pearson; D Pearson; S Shibahara; J Hofsteenge; R Chiquet-Ehrismann
Journal:  EMBO J       Date:  1988-10       Impact factor: 11.598

9.  Tenascin mediates cell attachment through an RGD-dependent receptor.

Authors:  M A Bourdon; E Ruoslahti
Journal:  J Cell Biol       Date:  1989-03       Impact factor: 10.539

10.  Site-restricted expression of cytotactin during development of the chicken embryo.

Authors:  K L Crossin; S Hoffman; M Grumet; J P Thiery; G M Edelman
Journal:  J Cell Biol       Date:  1986-05       Impact factor: 10.539

View more
  12 in total

1.  A binding site for homeodomain and Pax proteins is necessary for L1 cell adhesion molecule gene expression by Pax-6 and bone morphogenetic proteins.

Authors:  R Meech; P Kallunki; G M Edelman; F S Jones
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

2.  The transcription factor EGR1 regulates metastatic potential of v-src transformed sarcoma cells.

Authors:  Vladimír Cermák; Jan Kosla; Jirí Plachý; Katerina Trejbalová; Jirí Hejnar; Michal Dvorák
Journal:  Cell Mol Life Sci       Date:  2010-05-28       Impact factor: 9.261

3.  The neural restrictive silencer element can act as both a repressor and enhancer of L1 cell adhesion molecule gene expression during postnatal development.

Authors:  P Kallunki; G M Edelman; F S Jones
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

Review 4.  Tenascins and the importance of adhesion modulation.

Authors:  Ruth Chiquet-Ehrismann; Richard P Tucker
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-05-01       Impact factor: 10.005

5.  Bromocriptine and clozapine regulate dopamine 2 receptor gene expression in the mouse striatum.

Authors:  Anthony H Stonehouse; Frederick S Jones
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

6.  Regulation of the neuronal proteasome by Zif268 (Egr1).

Authors:  Allan B James; Ann-Marie Conway; Brian J Morris
Journal:  J Neurosci       Date:  2006-02-01       Impact factor: 6.167

7.  Macrophage/Microglia regulation of astrocytic tenascin: synergistic action of transforming growth factor-beta and basic fibroblast growth factor.

Authors:  G M Smith; J H Hale
Journal:  J Neurosci       Date:  1997-12-15       Impact factor: 6.167

8.  Transcription factor EGR1 directs tendon differentiation and promotes tendon repair.

Authors:  Marie-Justine Guerquin; Benjamin Charvet; Geoffroy Nourissat; Emmanuelle Havis; Olivier Ronsin; Marie-Ange Bonnin; Mathilde Ruggiu; Isabel Olivera-Martinez; Nicolas Robert; Yinhui Lu; Karl E Kadler; Tristan Baumberger; Levon Doursounian; Francis Berenbaum; Delphine Duprez
Journal:  J Clin Invest       Date:  2013-07-25       Impact factor: 14.808

9.  Multiple non-cell-autonomous defects underlie neocortical callosal dysgenesis in Nfib-deficient mice.

Authors:  Michael Piper; Randal X Moldrich; Charlotta Lindwall; Erica Little; Guy Barry; Sharon Mason; Nana Sunn; Nyoman Dana Kurniawan; Richard M Gronostajski; Linda J Richards
Journal:  Neural Dev       Date:  2009-12-04       Impact factor: 3.842

Review 10.  Tenascin-C: Form versus function.

Authors:  Sean P Giblin; Kim S Midwood
Journal:  Cell Adh Migr       Date:  2015       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.